Clinical trial Recruiting at 1 site Interventional Ages 6 and up

How phonology and sound sensitivity shape language in people with Williams syndrome

Official title: Phonological Constraints on Language Development in Individuals With Williams Syndrome

Run by Centre Hospitalier Universitaire, Amiens · NCT07285720 · Data updated 2026-11-12

This project tries to see if sensitivity to sound (hyperacusis) and reliance on phonological short-term memory explain why people with Williams syndrome often have strong verbal skills by comparing them to individuals with Down syndrome and typically developing peers using EEG-NIRS and questionnaires.

More Developmental Language Disorder trials

Quick facts

Study typeInterventional
Ages6 Years and up
SexAll
Enrollment130 (estimated)
SponsorCentre Hospitalier Universitaire, Amiens
Academic / other
Locations1 site (Amiens)
StatusRecruiting
StartedJuly 5, 2024
Main results expectedJuly 2026
Study endsJuly 2026
Registry record updatedDecember 16, 2025
Trial IDNCT07285720 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals with a genetic diagnosis of Williams syndrome or Down syndrome aged 6–17, typically developing children/teens matched by age (6–17), or adults aged 20–60 who do not have co-occurring autism or West syndrome.

Probably not a fit

People with co-occurring autism spectrum disorder or West syndrome, children outside the specified age ranges, or those seeking direct therapeutic benefit rather than research findings are unlikely to receive personal medical benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional protocol uses simultaneous EEG and near-infrared spectroscopy (EEG-NIRS) along with questionnaires and language/memory tasks to study phonological processing in Williams syndrome. Researchers will compare children and adolescents with Williams syndrome to peers with Down syndrome and to typically developing controls on tasks that challenge phonological short-term memory and during passive listening while recording physiological responses. The study includes standardized language and memory measures, sensory sensitivity questionnaires, and concurrent EEG-NIRS to capture neural responses to auditory stimuli. The goal is to determine whether hyperacusis and phonological short-term memory contribute to the atypical language profile seen in Williams syndrome.

Why it matters

Potential benefit: If successful, this work could clarify mechanisms behind verbal strengths in Williams syndrome and point to targeted approaches to support language and communication.

How similar studies have gone: Behavioral research has shown distinct phonological short-term memory profiles in Williams and Down syndromes, but using combined EEG-NIRS to link hyperacusis directly to language outcomes is a relatively novel approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* For SW and SD: genetic diagnosis and aged between 6- and 17 years old.
* For typical participants: any child, adolescent or young adult of the same developmental or chronological age (between 6 and 17 years of age)
* adult group (between 20 and 60 years).

Exclusion Criteria:

* Autistic Associated Disorders,
* West syndrome

Where it's running

  • CHU Amiens
    Amiens, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.